Dr. Ruiz is an Associate Physician at the Mohs and Dermatologic Surgery Center at Brigham and Women’s Faulkner Hospital, Assistant Professor in Dermatology at Harvard Medical School and Director of the High-Risk Skin Cancer Clinic at Dana Farber/Brigham and Women’s Hospital.
Dr. Ruiz’s career is dedicated to patient care, clinical innovation, education, and skin cancer research. She spends 60% of her time in outpatient clinical activities and the remainder of time is devoted to clinical research and education. The majority of her clinical time is spent performing Mohs micrographic surgery and one clinic a week is at Dana-Farber Cancer Institute. This clinic is a referral site for aggressive non-melanoma skin cancers and provides skin cancer surveillance to high-risk patients, including transplant patients and individuals with a history of a high-risk skin cancer. It is also is a site for two clinical trial for a programmed cell death protein 1 (PD-1) inhibitor for patients with locally advanced and metastatic cutaneous squamous cell carcinoma and basal cell carcinoma.